Revenue of $330.9 million in the first quarter of 2022 increased 27.3% from revenue of $260.0 million for the comparable prior-year period, representing a backlog conversion rate of 16.6%. Net new business awards were $423.0 million in the first quarter of 2022, representing an increase of 18.8%
Hundreds of thousands of people expected to be impacted by donation CINCINNATI --(BUSINESS WIRE)--Mar. 23, 2022-- Medpace (MEDP), a global clinical research organization (CRO), has partnered with Matthew 25: Ministries , a humanitarian and disaster relief organization, to fund aid shipments to
CINCINNATI --(BUSINESS WIRE)--Mar. 17, 2022-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2022 financial results after the market close on Monday, April 25, 2022 . The Company will host a conference call the following morning, Tuesday,
Revenue of $308.6 million in the fourth quarter of 2021 increased 18.8% from revenue of $259.7 million for the comparable prior-year period, representing a backlog conversion rate of 16.7%; Full year 2021 revenue of $1,142.4 million increased 23.4% from full year 2020.
CINCINNATI --(BUSINESS WIRE)--Jan. 4, 2022-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2021 financial results after the market close on Monday, February 14, 2022 . The Company will host a conference call the following
Revenue of $295.6 million in the third quarter of 2021 increased 28.3% from revenue of $230.4 million for the comparable prior-year period, representing a backlog conversion rate of 17.0%. Net new business awards were $408.0 million in the third quarter of 2021, representing an increase of 29.4%
CINCINNATI --(BUSINESS WIRE)--Sep. 7, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2021 financial results after the market close on Monday, October 25, 2021 . The Company will host a conference call the following morning, Tuesday,
CINCINNATI --(BUSINESS WIRE)--Aug. 30, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Baird’s Global Healthcare Conference Date: Tuesday, September 14, 2021 Presentation: 8:30 a.m.
Appointment of Jesse Geiger as President and Kevin Brady as Chief Financial Officer CINCINNATI --(BUSINESS WIRE)--Jul. 26, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the appointment of Jesse Geiger as president and Kevin Brady as chief financial officer, effective
Revenue of $278.3 million in the second quarter of 2021 increased 35.8% from revenue of $205.0 million for the comparable prior-year period, representing a backlog conversion rate of 17.1%. Net new business awards were $387.6 million in the second quarter of 2021, representing an increase of 52.5%
CINCINNATI --(BUSINESS WIRE)--May 27, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2021 financial results after the market close on Monday, July 26, 2021 . The Company will host a conference call the following morning, Tuesday, July
CINCINNATI --(BUSINESS WIRE)--May 18, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021 Presentation: 9:00 a.m.
Revenue of $260.0 million in the first quarter of 2021 increased 12.6% from revenue of $230.9 million for the comparable prior-year period, representing a backlog conversion rate of 16.9%. Net new business awards were $356.2 million in the first quarter of 2021, representing an increase of 44.2%
CINCINNATI --(BUSINESS WIRE)--Mar. 10, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2021 financial results after the market close on Monday, April 26, 2021 . The Company will host a conference call the following morning, Tuesday,
Revenue of $259.7 million in the fourth quarter of 2020 increased 13.0% from revenue of $229.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.1%; Full year 2020 revenue of $925.9 million increased 7.5% from full year 2019.
CINCINNATI --(BUSINESS WIRE)--Jan. 5, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021 . The Company will host a conference call the following
CINCINNATI --(BUSINESS WIRE)--Oct. 29, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Credit Suisse Healthcare Conference Date: Tuesday, November 10, 2020 Presentation: 9:30 a.m.
Revenue of $230.4 million in the third quarter of 2020 increased 6.5% from revenue of $216.2 million for the comparable prior-year period, representing a backlog conversion rate of 17.2%. Net new business awards were $315.4 million in the third quarter of 2020, representing an increase of 10.5%
CINCINNATI --(BUSINESS WIRE)--Sep. 2, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2020 financial results after the market close on Monday, October 26, 2020 . The Company will host a conference call the following morning, Tuesday,
CINCINNATI --(BUSINESS WIRE)--Aug. 27, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September: Baird's Global Healthcare Conference Date: Thursday, September 10, 2020 Presentation: 3:45 p.m.
Revenue of $205.0 million in the second quarter of 2020 decreased 4.3% from revenue of $214.1 million for the comparable prior-year period, representing a backlog conversion rate of 15.8%. Net new business awards were $254.1 million in the second quarter of 2020, representing a decrease of 9.0%
CINCINNATI --(BUSINESS WIRE)--May 26, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following two investor conferences in June: Jefferies Virtual Global Healthcare Conference Date: Wednesday, June 3, 2020 Presentation: 8:30 a.m.